Icoone Open Iconovo

Iconovo initiates structured sales process for ...

Inhalation Product Development | Iconovo

First granted ICOone® patent in the United Stat...

ICONOVO AB PUBLISHES THE ANNUAL REPORT 2023 IN ...

Iconovo is recruiting as a drive towards increa...

ICOone Nasal | Iconovo

Iconovo receives grant from Bill & Melinda Gate...

ICOpre | Iconovo

Iconovo’s ICOone® inhaler platform receives new...

Press Release Archives | Iconovo

ICOone – Iconovo

ICOone | Iconovo

Iconovo AB on LinkedIn: Learn more about ICOone...

Zenit.Iconovo

Iconovo attends Carnegie Healthcare Webinar | I...

Iconovo launches improved versions of nasal ICO...

ICOone | Iconovo

Sticker Maker - icoNOVO

Iconovo develops intranasally inhaled semagluti...

Iconovo releases Q2-2024 report | Iconovo

BEAUTY

Sticker Maker - icoNOVO

Iconovo AB on LinkedIn: New human factor study ...

Inhalation made easy with ICOone | Iconovo

Iconovo

[Video] Iconovo AB on LinkedIn: Study start for...

Iconovo AB na LinkedIn: #iconovo #inhalation #i...

See video presentations from Iconovo Capital Ma...

ICOpre | Iconovo

Iconovo to present positive data from a feasibi...

PRESSRELEASE New patent for ICOone | Iconovo

News | Iconovo

ICOONE - Procedure, Effects, Price • OT.CO Poland

Iconovo has reached several milestones during 2...

ICOpre | Iconovo